Literature DB >> 15839684

A designed synthetic analogue of 4-OT is specific for a non-natural substrate.

Norman Metanis1, Ehud Keinan, Philip E Dawson.   

Abstract

The substrate specificity of 4-oxalocrotonate tautomerase (4-OT) is characterized by electrostatic interactions between positively charged arginine (Arg) side chains on the enzyme and the dianionic substrate, 4-oxalocrotonate. To generate specific hydrogen-bonding interactions with a monoanionic substrate analogue, we have introduced a urea functional group into the active site by replacing arginine side chains with isosteric citrulline (Cit) residues. This design was based on the complementarity between the urea functionality of citrulline and the uncharged amide function of the substrate, as opposed to the guanidinium-carboxylate electrostatic interaction between the wild-type enzyme and the natural substrate. Indeed, the synthetic (Arg39Cit)4-OT analogue catalyzed the tautomerization of the non-natural monoamide-monoacid substrate while it was a poor catalyst for the natural diacid substrate. The specificity of (Arg39Cit)4-OT for the monoamide-monoacid substrate relative to that of the diacid substrate was found to be 740-fold greater than that of the wild-type enzyme for tautomerization of the non-natural substrate as compared with the natural one. The role of electrostatic interactions in the tautomerization of the monoamide-monoacid substrate was probed in detail with several other Arg to Cit analogues of this enzyme. This study has demonstrated that chemical manipulation of the functional groups within the active site of an enzyme can modify its catalytic activity and substrate specificity in a predictable way, suggesting that the incorporation of noncoded amino acids into proteins has great promise for the development of new enzymatic mechanisms and new binding interactions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15839684     DOI: 10.1021/ja050110b

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  5 in total

1.  Drug delivery using nanoparticle-stabilized nanocapsules.

Authors:  Xiao-Chao Yang; Bappaditya Samanta; Sarit S Agasti; Youngdo Jeong; Zheng-Jiang Zhu; Subinoy Rana; Oscar R Miranda; Vincent M Rotello
Journal:  Angew Chem Int Ed Engl       Date:  2011-01-10       Impact factor: 15.336

Review 2.  Recent developments of the quantum chemical cluster approach for modeling enzyme reactions.

Authors:  Per E M Siegbahn; Fahmi Himo
Journal:  J Biol Inorg Chem       Date:  2009-05-13       Impact factor: 3.358

3.  A residue outside the active site CXXC motif regulates the catalytic efficiency of Glutaredoxin 3.

Authors:  Talia Shekhter; Norman Metanis; Philip E Dawson; Ehud Keinan
Journal:  Mol Biosyst       Date:  2009-09-22

4.  Mutagenesis studies of substrate recognition and catalysis in the sortase A transpeptidase from Staphylococcus aureus.

Authors:  Matthew L Bentley; Erin C Lamb; Dewey G McCafferty
Journal:  J Biol Chem       Date:  2008-03-28       Impact factor: 5.157

5.  Swit_4259, an acetoacetate decarboxylase-like enzyme from Sphingomonas wittichii RW1.

Authors:  Lisa S Mydy; Zahra Mashhadi; T William Knight; Tyler Fenske; Trevor Hagemann; Robert W Hoppe; Lanlan Han; Todd R Miller; Alan W Schwabacher; Nicholas R Silvaggi
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-11-14       Impact factor: 1.056

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.